QA: ABBOTT LABORATORIES in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000001800_2023_ABBOTT_LABORATORIES.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000001800, ABBOTT LABORATORIES

  xvar xval
0 AssetsCurrent 25,224,000,000
1 IntangibleAssetsNetIncludingGoodwill 33,253,000,000
2 PropertyPlantAndEquipmentNet 9,162,000,000
3 remainder_Assets 6,799,000,000
4 LiabilitiesCurrent 15,489,000,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 19,142,000,000
8 SellingGeneralAndAdministrativeExpense 11,248,000,000
9 ResearchAndDevelopmentExpense 2,888,000,000
10 remainder_Expenses 3,944,000,000
11 remainder_Revenues 43,653,000,000
12 remainder_NetIncome 502,000,000
13 remainder_ComprehensiveNetIncome 323,000,000
  yvar yval
0 Assets 74,438,000,000
1 Liabilities 15,489,000,000
2 Expenses 37,222,000,000
3 Revenues 43,653,000,000
4 StockholdersEquity 58,949,000,000
5 NetIncome 6,933,000,000
6 ComprehensiveNetIncome 7,094,500,000
7 BaseVar 85,813,500,000
8 EconomicCapitalRatio 2.41

Edgar->Model Mapping

Feature Distribution

Change over Time